Daily non-political popular news in brief.

Women with breast cancer have less dermatitis when treated with IMRT

All women treated with radiation therapy for breast cancer are at risk of developing dermatitis -- a sometimes-painful skin condition caused by radiation as it makes its way through the skin to the tumor area and tissue within the breast. But researchers at Fox Chase Cancer Center say women being treated with intensity-modulated radiation therapy are less likely to have serious dermatitis.

Read more »

Keywords: women, breast, cancer, dermatitis, treated, imrt, dermatiti

« Previous | Next »

Similar news on "Women with breast cancer have less dermatitis when treated with IMRT":

1. Reduced dietary fat intake may decrease breast cancer recurrence
   12-16-2006 · EurekAlert!
   Reducing dietary fat intake may decrease the chance of a breast cancer recurrence in women who have been treated for early-stage breast cancer, according to a randomized, phase III trial in the December 20 issue of the Journal of the National Cancer Institute.
   Similar news · Read more »
   
2. Exceeding '5/day' guide for veggie, fruit intake doesn't reduce chance of breast cancer recurrence
   07-17-2007 · EurekAlert!
   Eating double the amount of veggies and fruits recommended by general dietary guidelines doesn't reduce the likelihood of breast cancer recurrence among women whose cancers were treated at an early stage of the disease, says a researcher at the Stanford University School of Medicine.
   Similar news · Read more »
   
3. Are women seeing the most experienced breast cancer surgeons?
   01-18-2007 · EurekAlert!
   Women who took more control over choosing their breast cancer surgeon were more likely to be treated by more experienced breast surgeons and at a hospital affiliated with an accredited cancer program, compared to women who were referred by another doctor or their health plan, according to a study led by researchers at the University of Michigan Comprehensive Cancer Center.
   Similar news · Read more »
   
4. Herceptin does not increase heart failure in patients long-term
   06-03-2007 · EurekAlert!
   Risk of congestive heart failure in women treated with trastuzumab and combination chemotherapy for early-stage breast cancer did not increase over time according to a five-year follow-up of National Surgical Adjuvant Breast and Bowel Project trial B-31 led by the University of Pittsburgh School of Medicine. Based on the findings, the research team developed a prediction model to help oncologists assess the risk of heart failure in individual breast cancer patients prior to treatment with Herceptin and chemotherapy.
   Similar news · Read more »
   
5. Survival shortened when ER/PR negative breast cancer spreads to the brain
   12-16-2007 · EurekAlert!
   Two studies from Mayo Clinic's site in Jacksonville, Fla., of women whose breast cancer spread to their brain, have found that women whose tumors do not have estrogen or progesterone receptors have the worst overall outcomes. Because of this, these patients should be treated aggressively after an initial diagnosis to help prevent such a metastasis, say the investigators, who presented their findings at the San Antonio Breast Cancer Symposium.
   Similar news · Read more »
   
6. Breast cancer survival rates improved by novel drug sequence, say researchers
   02-12-2007 · EurekAlert!
   Changing the way women are treated for breast cancer could improve their overall chance of survival, according to research published today in the Lancet. The new paper shows that switching to a drug called exemestane, two to three years after commencing standard therapy with the drug tamoxifen, can cut the risk of death for certain women by a further 17 percent compared with using tamoxifen alone.
   Similar news · Read more »
   
7. Herceptin does not increase heart failure in patients long term
   06-03-2007 · EurekAlert!
   Risk of congestive heart failure in women treated with trastuzumab and combination chemotherapy for early stage breast cancer did not increase over time according to a five-year follow up of National Surgical Adjuvant Breast and Bowel Project trial B-31 led by the University of Pittsburgh School of Medicine. Based on the findings, the research team developed a prediction model to help oncologists assess the risk of heart failure in individual breast cancer patients prior to treatment with Herceptin and chemotherapy.
   Similar news · Read more »
   
8. New radiation technique can greatly reduce painful skin burns in women with breast cancer
   11-06-2006 · EurekAlert!
   Breast cancer patients who undergo a new radiation technique called intensity modulated radiation therapy (IMRT) after surgery are three times less likely to have severe skin reactions from the treatment compared to standard radiation therapy, according to a study presented at the plenary session November 6, 2006, at the American Society for Therapeutic Radiology and Oncology's 48th Annual Meeting in Philadelphia. The study is the first of its kind to show how recent dramatic improvements in radiation treatments directly benefit patients.
   Similar news · Read more »
   
9. Breast cancer survivors experience long-term heart disease risk from radiotherapy
   03-06-2007 · EurekAlert!
   Women who were treated with radiation for breast cancer during the 1980s may be at an increased risk for heart disease compared with the general population, according to a new study in the March 7 Journal of the National Cancer Institute. Despite this increased risk of heart disease, radiation therapy has been previously shown to improve the chances of surviving breast cancer.
   Similar news · Read more »
   
10. Breast cancer is more aggressive in African-American women
    10-29-2007 · EurekAlert!
    African-American women are diagnosed with breast cancer at a younger age and have larger tumors and more lymph node involvement.
    Similar news · Read more »